COVID may have given real-world evidence the boost it needed to become routine, especially in areas that demand research innovation and advancement.
Leanne Larson
Advertisement
Senior Vice President, Real-World Evidence & Access, Parexel
Articles by Leanne Larson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
How will DTC Programs Impact PBMs?
4
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
5
